Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 1, 2009
Patent Application Number
10613272
Date Filed
July 3, 2003
Patent Primary Examiner
Patent abstract
The present invention is directed to a method of enhancing the immune response of a patient relative to the normal immune response, by administering isoaspartyl-modified proteins, peptides, or cells, to a patient. The present invention is also directed to vaccines containing the isoaspartyl-modified proteins, peptides, or cells, as well as antibodies reactive with the isoaspartyl-modified proteins, peptides, or cells.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.